|
Roche Molecular Diagnostics' microbiology-related PCR-based testing products include an FDA-approved in vitro diagnostic test
for the rapid and reliable detection of M. tuberculosis in untreated patients who have AFB (Acid Fast bacilli) positive smear
results within hours as opposed to weeks with conventional culture methods. Roche also offers detection kits for two of the most
common non-tuberculosis bacteria, M. avium and M. intracellulare (MAC).
In addition, Roche is developing a portfolio of assays for screening and diagnosis of Healthcare Associated Infections. The first assay to be introduced in this field is the LightCycler® SeptiFast Test MGRADE, which provides species identification within 6 hours of pathogens causing blood stream infections*.
Please note: Not all products are available in all countries.
Diagnostic Assays
Kits for Research
Kits are available for the following parameters:
Instruments
* Not available in the United States
** Available only in Japan
*** For Research Use Only. Not for use in diagnostic procedures. Not available in the United States.
**** For General Laboratory Use. For in vitro use only
***** Not available in the United States; Available in Japan
|